Corrigendum: Understanding greater cardiomyocyte functions on aligned compared to random carbon nanofibers in plga (Int J Nanomedicine., (2015) 10(1), (89-96), 10.2147/IJN.S74173);Understanding greater cardiomyocyte functions on aligned compared to random carbon nanofibers in PLGA

International Journal of Nanomedicine

Volumn 10, Issue , 2014, Pages 89-96

  Asiri, Abdullah M ^a   Marwani, Hadi M ^a   Khan, Sher Bahadar ^a   Webster, Thomas J ^a,b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b Northeastern University   (United States)

Author keywords

Aligned; Anisotropy; Carbon nanofibers; Cardiomyocytes; Fibronectin; Laminin; Mechanism; Nanotechnology; Poly(lactic co glycolic acid); Vitronectin

Indexed keywords

ALPHA ACTIN; ALPHA SARCOMERIC ACTIN; CARBON NANOFIBER; CONNEXIN 43; FIBRONECTIN; LAMININ; POLYGLACTIN; TROPONIN T; UNCLASSIFIED DRUG; VITRONECTIN; ACTIN; BIOLOGICAL MARKER; CARBON; LACTIC ACID; NANOFIBER; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; PROTEIN ADSORPTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WETTABILITY; CARDIAC MUSCLE CELL; CELL CULTURE; CHEMICAL PHENOMENA; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; METABOLISM;

ACTINS; BIOMARKERS; CARBON; CELL ADHESION; CELLS, CULTURED; CONNEXIN 43; FIBRONECTINS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LACTIC ACID; LAMININ; MYOCYTES, CARDIAC; NANOFIBERS; POLYGLYCOLIC ACID; TROPONIN T; VITRONECTIN;

EID: 84919653073     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S320915     Document Type: Erratum

References (26)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: heart disease and stroke statistics - 2010 update. Circulation. 2010;121:948-954.
2. Jain AK, Knight C. Myocardial infarction - new definitions and implications. Medicine. 2010;38:421-423.
3. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol. 2005;23:845-856.
4. Locca D, Bucciarelli-Ducci C, Ferrante G, et al. New universal definition of myocardial infarction: applicable after complex percutaneous coronary interventions? JACC Cardiovasc Interv. 2010;3:950-958.
5. Thygesen K, Alpert JS, White HD; on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50:2173-2195.
6. Kretlow JD, Klouda L, Mikos AG. Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev. 2007;59:263-273.
7. Wang T, Wu D-Q, Jiang X-J, et al. Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling. Eur J Heart Fail. 2009;11:14-19.
8. Li XY, Wang T, Jiang XJ, et al. Injectable hydrogel helps bone marrow-derived mononuclear cells restore infarcted myocardium. Cardiology. 2010;115:194-199.
9. Dai W, Wold LE, Dow JS, Kloner RA. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol. 2005;46:714-719.
10. Huang NF, Yu J, Sievers R, Li S, Lee RJ. Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng. 2005;11:1860-1866.
11. Roberts-Thomson KC, Kistler PM, Sanders P, et al. Fractionated atrial electrograms during sinus rhythm: relationship to age, voltage, and conduction velocity. Heart Rhythm. 2009;6:587-591.
12. Asiri AM, Marwani HM, Khan SB, Webster TJ. Greater cardiomyocyte density on aligned compared to random carbon nanofibers in polymer composites. Int J Nanomedicine. 2014;9(1):5533-5539.
13. Engelmayr GC, Cheng M, Bettinger CJ, Borenstein JT, Langer R, Freed LE. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater. 2008;7(12):1003-1010.
14. Jalil J, Doering C, Janicki J, Pick R, Shroff S, Weber K. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res. 1989;64(6):1041-1050.
15. Mirsky I, Parmley WW. Assessment of passive elastic stiffness for isolated heart muscle and the intact heart. Circ Res. 1973;33(2):233-243.
16. Boublik J, Park H, Radisic M, et al. Mechanical properties and remodeling of hybrid cardiac constructs made from heart cells, fibrin, and biodegradable, elastomeric knitted fabric. Tissue Eng. 2005;11(7-8):1122-1132.
17. Phillips CA, Petrofsky JS. Myocardial material mechanics: characteristic variation of the circumferential and longitudinal systolic moduli in left ventricular dysfunction. J Biomech. 1984;17(8):561-568.
18. Stout DA, Basu B, Webster TJ. Poly(lactic-co-glycolic acid): carbon nanofiber composites for myocardial tissue engineering applications. Acta Biomater. 2011;7(8):3101-3112.
19. Stout DA, Yoo J, Santiago-Miranda AN, Webster TJ. Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular applications. Int J Nanomedicine. 2012;7:5653-5669.
20. Zheng H-x, Liu S-s, Tian W-m, Yan H-j, Zhang Y, Li Y. A three-dimensional in vitro culture model for primary neonatal rat ventricular myocytes. Curr Appl Phys. 2012;12(3):826-833.
21. Tribulova N, Shneyvays V, Mamedova LK, et al. Enhanced connexin-43 and α-sarcomeric actin expression in cultured heart myocytes exposed to triiodo-l-thyronine. J Mol Histol. 2004;35(5):463-470.
22. Carrier L, Boheler KR, Chassagne C, et al. Expression of the sarcomeric actin isogenes in the rat heart with development and senescence. Circ Res. 1992;70(5):999-1005.
23. Khang D, Kim SY, Liu-Synder P, Palmore GTR, Durbin SM, Webster TJ. Enhanced fibronectin adsorption on carbon nanotubes/poly(carbonate) urethane: independent role of surface nano roughness and associated surface energy. Biomaterials. 2007;28(32):4745-4768.
24. Pedrotty DM, Koh J, Davis BH, Taylor DA, Wolf P, Niklason LE. Engineering skeletal myoblasts: roles of three-dimensional culture and electrical stimulation. Am J Physiol Heart Circ Physiol. 2005;288:H1620-H1626.
25. Kisin ER, Murray AR, Sargent L, et al. Genotoxicity of carbon nanofibers: are they potentially more or less dangerous than carbon nanotubes or asbestos? Toxicol Appl Pharmacol. 2011;252(1):1-10.
26. Christman KL, Lee RJ. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol. 2006;48(5):907-913.